Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015
Share:
Email this page Share this on LinkedIn Share this on Twitter

Biotech Showcase™ 2015 Press Releases

News for Biotech Showcase™ 2015 will be available soon

Biotech Showcase 2014 press releases

January 23, 2014Unprecedented Biotech Showcase™ 2014 attendance reflects investor appetite for biotech innovationOver 1,700 delegates attend investor conference in San Francisco
The sixth annual Biotech Showcase investor conference wrapped up last week in San Francisco with record attendance. The event, every January at Parc 55 Wyndham San Francisco - Union Square, is an investment weathervane for the biotech industry. "There was clearly significant momentum behind the conference this year. The event benefited from the up market for life sciences c...  more ►

January 9, 2014Biotech Investing Strategies in 2014 is key topic bringing investors to San Francisco for Biotech Showcase™ 2014 next week, January 13 Innovative presenting companies comprising early stage and biotech are on the program for the sixth annual Biotech Showcase investor and partnering conference taking place in San Francisco next week. The event, held January 13–15 at Parc 55 Wyndham San Francisco - Union Square, already has 963 companies and 1,480 delegates attending, providing a forum for investors to ca...  more ►

December 18, 2013Biotech Showcase™ program speakers have their fingers on the pulse of biotech Biotech Showcase investor and partnering conference returns to San Francisco for the sixth year. This established innovation showcase for life science investors will be held January 13–15, 2014 at Parc 55 Wyndham San Francisco - Union Square. The event draws executives representing top public and private biotech and life science companies and investors seeking new opport...  more ►

November 21, 2013Sixth Annual Biotech Showcase™ returns to San Francisco January 13–15Event is annual investing and partnering benchmark for life science executives and investors
The sixth annual Biotech Showcase investor and partnering conference will be held January 13–15, 2014 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square. The event is an established innovation showcase for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerg...  more ►


partnering360® Blog

September 23, 2014 BioPharm America™ Day 1: 13 Take Aways This week we’re in Boston for BioPharm America™.   Today, we’re recapping the top insights we gained during the day.  The day focused heavily on looking at the benefit of the patient and how important it is to differentiate your product from others and create a better benefit so... more ►

September 21, 2014 European biotech IPOs are slow but steady 2014 has been a strong year for US biotech IPOs, and the venture community has been taking on more risky upstart endeavors with flexible deal terms. According to a September 18 Financial Times article, the Nasdaq biotech index is on the rise again, up 20 percent since January of this year. IPO... more ►

September 19, 2014 Who can you meet next week at BioPharm America™? Next week, 900 plus Pharmaceutical professionals, Innovators and investors will meet in Boston for the BioPharma America ™ event.  With the power of partneringONE®, these companies will be able to meet and form strategic relationships that will move the industry forward. Here are just a few of... more ►

September 17, 2014 FierceBiotech’s 2014 Fierce 15 winners to be announced live at BioPharm America™ FierceBiotech’s annual list of the Fierce 15 involves a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential... more ►

September 16, 2014 Innovation at Sanofi Sanofi looks for innovation in it’s drug portfolio in a variety of places – from the acquisitions they’ve made in their business to partnerships with venture capital, biotech and Pharma.  In a recent article at Insight, Gary J. Nabel, Senior VP, CSO and deputy to the President for... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015